Yasuyuki Todoroki

40PUBLICATIONS
125CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Predictive and prognostic markersNephrology and urologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|May 18, 2026
Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry.

|Mar 31, 2026
Rheumatoid arthritis at a turning point in the era of targeted therapies.

Satoshi Kubo

|Mar 09, 2026
Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long-Term Multicenter Observational Study.

Takafumi Aritomi, Koshiro Sonomoto, Shingo Nakayamada

|Feb 05, 2026
Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry.

Hidenori Sakai, Koshiro Sonomoto, Shingo Nakayamada

|Jan 16, 2026
Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry.

Masanobu Ueno, Koshiro Sonomoto, Hiroaki Tanaka

|Sep 08, 2025
Distribution of nailfold videocapillaroscopy parameters in systemic lupus erythematosus and their association with disease activity: an international blinded case-control analysis on behalf of the EULAR study group on microcirculation in rheumatic diseases.

Francesca Ingegnoli, Nicola Ughi, Valeria Riccieri

Pageof 7

Frequent Collaborators

30 joint publications

Yoshiya Tanaka

14 joint publications

Yusuke Miyazaki

10 joint publications

Koshiro Sonomoto

8 joint publications

Masanobu Ueno